55 related articles for article (PubMed ID: 1980599)
21. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
[TBL] [Abstract][Full Text] [Related]
22. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
23. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
24. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells.
Nagai M; Natsumeda Y; Weber G
Cancer Res; 1992 Jan; 52(2):258-61. PubMed ID: 1345808
[TBL] [Abstract][Full Text] [Related]
25. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
Vethe NT; Bremer S; Bergan S
Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
[TBL] [Abstract][Full Text] [Related]
26. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599
[TBL] [Abstract][Full Text] [Related]
27. Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis.
Yalowitz JA; Jayaram HN
Anticancer Res; 2000; 20(4):2329-38. PubMed ID: 10953293
[TBL] [Abstract][Full Text] [Related]
28. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
29. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
30. Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target.
Pankiewicz KW; Patterson SE; Black PL; Jayaram HN; Risal D; Goldstein BM; Stuyver LJ; Schinazi RF
Curr Med Chem; 2004 Apr; 11(7):887-900. PubMed ID: 15083807
[TBL] [Abstract][Full Text] [Related]
31. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
Weber G; Yamaji Y; Nagai M; Natsumeda Y; Jayaram HN; Zhen WN; Paulik E
Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
[TBL] [Abstract][Full Text] [Related]
32. Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase.
Yalowitz JA; Jayaram HN
Curr Med Chem; 2002 Apr; 9(7):749-58. PubMed ID: 11966438
[TBL] [Abstract][Full Text] [Related]
33. Regulation and role of inosine-5'-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation.
Huberman E; Glesne D; Collart F
Adv Exp Med Biol; 1994; 370():741-6. PubMed ID: 7661012
[No Abstract] [Full Text] [Related]
34. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
Jäger W; Salamon A; Szekeres T
Curr Med Chem; 2002 Apr; 9(7):781-6. PubMed ID: 11966442
[TBL] [Abstract][Full Text] [Related]
35. Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.
Szekeres T; Sedlak J; Novotny L
Curr Med Chem; 2002 Apr; 9(7):759-64. PubMed ID: 11966439
[TBL] [Abstract][Full Text] [Related]
36. Toxicity and efficacy of benzamide riboside in cancer chemotherapy models.
Jayaram HN; Yalowitz JA; Arguello F; Greene JF
Curr Med Chem; 2002 Apr; 9(7):787-92. PubMed ID: 11966443
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]